NCT04927104

Brief Summary

In this study, 10 subjects will be underwent total knee arthroplasty with PEEK knee prosthesis and be followed up 3, 6, and 12 months after surgery. The safety of the knee prosthesis for total knee arthroplasty will be investigated based on X-ray, magnetic resonance imaging, thin-section CT, hematological indexes, knee function, complications and the occurrence of serious adverse events at the 12-month follow-up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 15, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

June 25, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 29, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

September 7, 2022

Status Verified

September 1, 2022

Enrollment Period

9 months

First QC Date

June 10, 2021

Last Update Submit

September 3, 2022

Conditions

Keywords

TKAPEEK Knee Prosthesis

Outcome Measures

Primary Outcomes (1)

  • Safety measures at 12 months after surgery

    The expected incidence of device-related complications within 12 months after surgery is 0.

    12 months

Secondary Outcomes (5)

  • X-ray examination

    At 3 and 12 months postoperatively

  • CT

    one week and 12 months after surgery

  • MRI

    3 and 12 months after surgery

  • Hematological examination indexes 3 and 12 months after surgery

    3 and 12 months after surgery

  • Excellent and good rates of the KSS knee scoring system at 3,6, 12 months postoperatively

    3,6, 12 months after surgery

Other Outcomes (1)

  • Incidence of other complications

    3,6, 12 months after surgery

Study Arms (1)

PEEK Knee Prosthesis

EXPERIMENTAL

In this study, 10 subjects will be underwent total knee arthroplasty with PEEK knee prosthesis.

Device: PEEK Knee Prosthesis

Interventions

After subjects drop out of the study for any reason, the researchers can perform revision surgery using the prosthetic joint that is now routinely used.

PEEK Knee Prosthesis

Eligibility Criteria

Age55 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female subjects aged 55 years of age or older and less than 74 years of age, younger subjects should have urgent need for surgery.
  • Subjects skeletal maturity.
  • Subjects appropriate for total knee replacement, such as noninflammatory degenerative joint diseases (such as osteoarthritis, traumatic arthritis, or ischemic necrosis); Inflammatory degenerative joint diseases (including rheumatoid arthritis); Correction of functional deformity.
  • The diseased side knee appropriate for primary total knee arthroplasty .
  • Subjects or guardian is willing and able to sign the informed consent form .

You may not qualify if:

  • Subjects with knee instability or abnormal gait caused by neuromuscular insufficiency.
  • Subjects with bilateral knee joint disease who are expected to require replacement of both knees during the course of the study (i.e., within the next 12 months) .
  • Alcoholics, drug addicts and drug abusers.
  • Subjects with severe diabetes (fasting blood glucose \> 10mmol/L)
  • Body Mass Index, BMI\>35.
  • Female subjects who are pregnant or lactating.
  • Subjects have disease limited their participation in the investigation or have an existing condition that would compromise their participation and follow-up in this clinical investigation.
  • Other conditions, in the opinion of the Investigator, are inappropriate for participation in this clinical investigation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renji Hospital,Shanghai Jiao Tong University School of Medicine

Shanghai, 200127, China

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • You Wang, MD

    RenJi Hospital

    PRINCIPAL INVESTIGATOR
  • Teng Long, MD

    RenJi Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: In this study, 10 subjects will be underwent total knee arthroplasty with PEEK knee prosthesis and be followed up 3, 6, and 12 months after surgery. The safety of the knee prosthesis for total knee arthroplasty will be investigated based on X-ray, magnetic resonance imaging, thin-section CT, hematological indexes, knee function, complications and the occurrence of serious adverse events at the 12-month follow-up.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prospective, Single-arm, Single-center Exploratory Study on Safety of PEEK Knee Prosthesis

Study Record Dates

First Submitted

June 10, 2021

First Posted

June 15, 2021

Study Start

June 25, 2021

Primary Completion

March 29, 2022

Study Completion

December 30, 2022

Last Updated

September 7, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations